Research Article

Clinical Characteristics of 162 Patients with Drug-Induced Liver and/or Kidney Injury

Table 8

Univariate analysis of measurement data of kidney injury group, simultaneous liver and kidney injury group, and liver injury group.

Kidney injury groupLiver and kidney injury groupLiver injury groupF value of variance analysis value

Age (y)51.23 ± 16.91150.88 ± 14.31849.76 ± 14.9670.0840.92
Weight (kg)63.25 ± 11.27465.75 ± 9.24764.78 ± 11.6980.710.493
Cholesterol (mmol/L)4.3516 ± 1.65114.2231 ± 1.16373.8328 ± 0.90361.2570.287
Percentage of neutrophils (%)67.1323 ± 19.186557.9312 ± 16.034559.2480 ± 32.56613.0730.049

Kidney injury groupLiver and kidney injury groupLiver injury groupStatistics of rank-sum test value

Triglyceride (mmol/L)M = 1.37, Q = 0.9751.6725 ± 0.86261.5056 ± 0.63792.4540.293
Fasting blood glucose (mmol/L)M = 5.4150, Q = 1.44505.6264 ± 1.46505.9216 ± 2.06460.9620.618
White blood cell (109/L)6.9263 ± 4.8850M = 5.73, Q = 2.9955.9713 ± 2.08411.0620.588
INRM = 0.99, Q = 0.1251.099 ± 0.18281.0336 ± 0.19943.2980.192

INR: the international standardized ratio. M means median, and Q means interquartile range.